Chemo Research Sl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHEMO RESEARCH SL, and what generic alternatives to CHEMO RESEARCH SL drugs are available?
CHEMO RESEARCH SL has three approved drugs.
There are seven US patents protecting CHEMO RESEARCH SL drugs.
There are sixteen patent family members on CHEMO RESEARCH SL drugs in nine countries and forty-two supplementary protection certificates in fourteen countries.
Summary for Chemo Research Sl
| International Patents: | 16 |
| US Patents: | 7 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Chemo Research Sl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemo Research Sl | BENZNIDAZOLE | benznidazole | TABLET;ORAL | 209570-002 | Aug 29, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Chemo Research Sl | BENZNIDAZOLE | benznidazole | TABLET;ORAL | 209570-001 | Aug 29, 2017 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | 10,238,634 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | 8,658,678 | ⤷ Subscribe | ⤷ Subscribe | |||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | 7,893,097 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Chemo Research Sl | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 211783-003 | Aug 10, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | 8,877,792 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Chemo Research Sl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2009097143 | ⤷ Subscribe |
| China | 107823123 | ⤷ Subscribe |
| Argentina | 070406 | ⤷ Subscribe |
| China | 103763925 | ⤷ Subscribe |
| Brazil | 112013033759 | ⤷ Subscribe |
| Japan | 2014518272 | ⤷ Subscribe |
| Australia | 2016200825 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chemo Research Sl Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1453521 | C 2015 029 | Romania | ⤷ Subscribe | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
| 2861072 | 2024C/512 | Belgium | ⤷ Subscribe | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL, EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE (Y COMPRIS SOUS FORME HEMIHYDRATEE) ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
| 1380301 | CA 2009 00017 | Denmark | ⤷ Subscribe | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
| 1453521 | 15C0050 | France | ⤷ Subscribe | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
| 1214076 | 49/2008 | Austria | ⤷ Subscribe | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
| 2782584 | 21C1058 | France | ⤷ Subscribe | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), Y COMPRIS SOUS FORME HEMIHYDRATEE, ET DE LA PROGESTERONE; NAT. REGISTRATION NO/DATE: NL51886 20210421; FIRST REGISTRATION: BE - BE582231 20210406 |
| 1214076 | C01214076/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
